Omalizumab: a future innovation for treatment of severe ocular allergy?

Author： Williams Patricia B   Sheppard Jr John D  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.5, Iss.12, 2005-12, pp. : 1603-1609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omalizumab for treatment of allergic rhinitis

By Vashisht Priyanka  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 6, 2013-08 ,pp. : 933-945

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels

By Yalcin Arzu Didem  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1335-1341

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab for the treatment of severe psoriasis and psoriatic arthritis

By Papoutsaki Marina   Costanzo Antonio   Chimenti Maria-Sole   Chimenti Sergio  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 3, 2008-03 ,pp. : 363-370

Informa Healthcare

Access to resources Recommend Favorite

Drotrecogin alfa (activated): the treatment for severe sepsis?

By Vincent Jean-Louis  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 11, 2007-11 ,pp. : 1763-1777

Informa Healthcare

Access to resources Recommend Favorite

Drotrecogin alfa: a new approach in the treatment of severe sepsis

By Vincent Jean-Louis  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 6, 2002-08 ,pp. : 659-664

Informa Healthcare

Access to resources Recommend Favorite